Integer price target lowered to $145 from $154 at KeyBanc

KeyBanc analyst Brett Fishbin lowered the firm’s price target on Integer (ITGR) to $145 from $154 and keeps an Overweight rating on the shares. The firm believes underlying MedTech trends remain mostly positive heading into Q1 earnings season, but is lowering several price targets to reflect macro concerns around the potential impact of tariffs as well as an increased risk of recession.